| Nome |
# |
|
Translation of bergamot essential oil in clinical trial for control of behavioral and psychological symptoms of dementia (BPSD), file 86f913e6-cf0e-4854-9b89-a93be17c59e9
|
26
|
|
Pain and agitation treatment in severe dementia patients: the need for Italian Mobilization–Observation–Behaviour–Intensity–Dementia (I-MOBID2) Pain Scale translation, adaptation and validation with psychometric testing, file 3f0e47c2-1a94-4521-8321-8d8954812420
|
10
|
|
Antinociceptive effect of inhalation of the essential oil of bergamot in mice, file ddc632d4-acc4-321f-e053-1705fe0abc09
|
8
|
|
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies, file ddc632d6-08ef-321f-e053-1705fe0abc09
|
8
|
|
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice, file ddc632d6-08e3-321f-e053-1705fe0abc09
|
6
|
|
New trends in pharmacological control of neuropsychiatric symptoms of dementia, file ddc632d6-1134-321f-e053-1705fe0abc09
|
6
|
|
Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia, file ddc632d6-1173-321f-e053-1705fe0abc09
|
6
|
|
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-like Behaviour in Female Rats, file ddc632d6-2039-321f-e053-1705fe0abc09
|
6
|
|
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine, file 12bba147-b932-472d-98fe-f167f3cae834
|
5
|
|
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol, file 1dafa75a-77ea-44fd-a7ce-b0762116f1b6
|
5
|
|
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy., file ddc632d6-0ad7-321f-e053-1705fe0abc09
|
5
|
|
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review, file ddc632d6-2c8a-321f-e053-1705fe0abc09
|
5
|
|
Translational Value of the Transdermal Administration of
Bergamot Essential Oil and of Its Fractions, file 25421dff-1782-4817-bc5b-95c2d7a25457
|
4
|
|
Bergamot essential oil attenuates anxiety-like behaviour in rats, file ddc632d3-8f80-321f-e053-1705fe0abc09
|
4
|
|
Contribution of histamine to nociceptive behaviors induced by intrathecally administered cholecystokinin-8, file ddc632d6-08e5-321f-e053-1705fe0abc09
|
4
|
|
Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A, file ddc632d6-095d-321f-e053-1705fe0abc09
|
4
|
|
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy, file 172cfd2b-3ddc-41dc-9615-9f42fd8f6413
|
3
|
|
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia, file 571d9a21-e92b-4ac3-9bad-d88ee3b60976
|
3
|
|
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence, file cbde884f-817f-447c-9372-bb5ee8b66388
|
3
|
|
Unbiased research is needed for rational translation of essential oils in clinic, file d153e0bf-d591-4d87-b197-863df3f2cfad
|
3
|
|
Aging brain: In search for better neurotherapeutics, file ddc632d3-e635-321f-e053-1705fe0abc09
|
3
|
|
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats, file ddc632d5-04c0-321f-e053-1705fe0abc09
|
3
|
|
Pattern of triptans use: a retrospective prescription study in Calabria, Italy, file ddc632d5-0b0b-321f-e053-1705fe0abc09
|
3
|
|
Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance, file ddc632d5-4f6e-321f-e053-1705fe0abc09
|
3
|
|
Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia, file ddc632d5-f97b-321f-e053-1705fe0abc09
|
3
|
|
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs, file ddc632d6-113b-321f-e053-1705fe0abc09
|
3
|
|
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders, file e88fc5d4-e19d-46af-908e-3c24ae045ca4
|
3
|
|
Requirements for translation in clinical trials of aromatherapy: the case of the essential oil of bergamot (BEO) for the management of agitation in severe dementia, file 5fd5bda1-5168-4aa7-898a-78504caa2a7e
|
2
|
|
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal, file dd5ed8ef-0a51-45dd-85d9-7950cb7c5b7c
|
2
|
|
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms, file ddc632d3-6518-321f-e053-1705fe0abc09
|
2
|
|
Opioids Resistance in Chronic Pain Management, file ddc632d3-bc4c-321f-e053-1705fe0abc09
|
2
|
|
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy, file ddc632d4-db0d-321f-e053-1705fe0abc09
|
2
|
|
Behavioral effects of continuously administered bergamot essential oil on mice with partial sciatic nerve ligation, file ddc632d6-061c-321f-e053-1705fe0abc09
|
2
|
|
Neuropharmacology of the neuropsychiatric symptoms of dementia and role of pain: Essential oil of bergamot as a novel therapeutic approach, file ddc632d6-08eb-321f-e053-1705fe0abc09
|
2
|
|
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy, file ddc632d6-08ed-321f-e053-1705fe0abc09
|
2
|
|
Nanotechnology-based deliviery system of bergamot essential oil, method of preparation of the system and uses thereof., file ddc632d6-0eb1-321f-e053-1705fe0abc09
|
2
|
|
Efficacy of essential oils in pain: a systematic review and meta-analysis of preclinical evidence, file ddc632d6-0f15-321f-e053-1705fe0abc09
|
2
|
|
Aromatherapy in stroke patients: is it time to begin?, file ddc632d6-13ab-321f-e053-1705fe0abc09
|
2
|
|
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis, file 1754c4a0-a6c7-44d8-b96b-04fdbcab3c82
|
1
|
|
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA, file 2b750bec-e531-495c-bf21-fd76348badb5
|
1
|
|
Essential oils-induced analgesia and related translation for the management of agitation in dementia, file 36515a41-79d9-495a-b84a-8fab5f5d0f3b
|
1
|
|
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia, file 3bf3192f-1438-4860-aba2-f4c7a7db18bd
|
1
|
|
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis, file 4f0d7b7b-608a-414f-98d8-e02299e947d8
|
1
|
|
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia, file 58671dc0-3dc0-4af7-bce3-0f12fdb81b4c
|
1
|
|
Proposal of combination therapies to treat refractory chronic migraine., file 601ac266-0d6f-4a2d-8f04-3cdaf6919ca5
|
1
|
|
Dementia therapeutics and cognitive rehabilitation, file b61cbf99-6e6d-4271-aba8-d76fc8e04345
|
1
|
|
Focus on zavegepant: the first intranasal third-generation gepant, file c197e8dd-9895-4838-bce1-e48da922e3f6
|
1
|
|
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol., file d1801f01-4720-40a9-8249-9c6f104f4ad1
|
1
|
|
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent, file ddc632d5-3e3d-321f-e053-1705fe0abc09
|
1
|
|
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab, file ddc632d5-f905-321f-e053-1705fe0abc09
|
1
|
|
Pattern of treatment of behavioral and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a center for cognitive disturbances and dementia, file ddc632d6-0776-321f-e053-1705fe0abc09
|
1
|
|
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis, file ddc632d6-0a85-321f-e053-1705fe0abc09
|
1
|
|
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography, file ddc632d6-1a6b-321f-e053-1705fe0abc09
|
1
|
|
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics, file ddc632d6-1e0a-321f-e053-1705fe0abc09
|
1
|
|
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, file ed0af90d-1b3b-40bc-b8e8-7680e0dcd93b
|
1
|
|
Preclinical evidence that mGluR2/3 and mGluR5 antagonists differently modulate motor behaviour induced by bergamot essential oil, file ef26858d-d959-4055-bb7c-c6f284e54be7
|
1
|
|
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP, file f647d638-29e7-4161-b4cd-600a9416963f
|
1
|
|
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play, file f9df1135-a10e-47a0-83f3-22ab194fdc89
|
1
|
| Totale |
187 |